TP53 and cancer: In particular, ccRCC is a clear example of cancer in which despite wild-type p53 status, a poor response to conventional anti-cancer treatments is occurring, thus ccRCC represents an extraordinary example of the importance of p53 pathway alterations in therapy resistance.